De Vriese AS - Search Results

1

Creatine supplementation does not decrease total plasma homocysteine in chronic hemodialysis patients.

Taes YE, Delanghe JR, De Bacquer D, Langlois M, Stevens L, Geerolf I, Lameire NH, De Vriese AS. Taes YE, et al. Among authors: de vriese as, de bacquer d. Kidney Int. 2004 Dec;66(6):2422-8. doi: 10.1111/j.1523-1755.2004.66019.x. Kidney Int. 2004. PMID: 15569335 Free article. Clinical Trial.

2

Diabetes-induced microvascular dysfunction in the hydronephrotic kidney: role of nitric oxide.

De Vriese AS, Stoenoiu MS, Elger M, Devuyst O, Vanholder R, Kriz W, Lameire NH. De Vriese AS, et al. Kidney Int. 2001 Jul;60(1):202-10. doi: 10.1046/j.1523-1755.2001.00787.x. Kidney Int. 2001. PMID: 11422752 Free article.

3

Prohepcidin accumulates in renal insufficiency.

Taes YE, Wuyts B, Boelaert JR, De Vriese AS, Delanghe JR. Taes YE, et al. Among authors: de vriese as. Clin Chem Lab Med. 2004 Apr;42(4):387-9. doi: 10.1515/CCLM.2004.069. Clin Chem Lab Med. 2004. PMID: 15147148

4

Creatine supplementation decreases homocysteine in an animal model of uremia.

Taes YE, Delanghe JR, De Vriese AS, Rombaut R, Van Camp J, Lameire NH. Taes YE, et al. Among authors: de vriese as. Kidney Int. 2003 Oct;64(4):1331-7. doi: 10.1046/j.1523-1755.2003.00206.x. Kidney Int. 2003. PMID: 12969151 Free article.

5

Effect of dialyser membrane pore size on plasma homocysteine levels in haemodialysis patients.

De Vriese AS, Langlois M, Bernard D, Geerolf I, Stevens L, Boelaert JR, Schurgers M, Matthys E. De Vriese AS, et al. Nephrol Dial Transplant. 2003 Dec;18(12):2596-600. doi: 10.1093/ndt/gfg437. Nephrol Dial Transplant. 2003. PMID: 14605283

6

Rifampicin-associated acute renal failure: pathophysiologic, immunologic, and clinical features.

De Vriese AS, Robbrecht DL, Vanholder RC, Vogelaers DP, Lameire NH. De Vriese AS, et al. Am J Kidney Dis. 1998 Jan;31(1):108-15. doi: 10.1053/ajkd.1998.v31.pm9428460. Am J Kidney Dis. 1998. PMID: 9428460 Review.

7

Recent concepts in the molecular biology of the peritoneal membrane - implications for more biocompatible dialysis solutions.

Mortier S, De Vriese AS, Lameire N. Mortier S, et al. Among authors: de vriese as. Blood Purif. 2003;21(1):14-23. doi: 10.1159/000067867. Blood Purif. 2003. PMID: 12566656 Review.

8

Global protein and histone arginine methylation are affected in a tissue-specific manner in a rat model of diet-induced hyperhomocysteinemia.

Esse R, Florindo C, Imbard A, Rocha MS, de Vriese AS, Smulders YM, Teerlink T, Tavares de Almeida I, Castro R, Blom HJ. Esse R, et al. Among authors: de vriese as. Biochim Biophys Acta. 2013 Oct;1832(10):1708-14. doi: 10.1016/j.bbadis.2013.05.013. Epub 2013 May 22. Biochim Biophys Acta. 2013. PMID: 23707560 Free article.

9

Neoangiogenesis in the peritoneal membrane: does it play a role in ultrafiltration failure?

De Vriese AS, Mortier S, Lameire NH. De Vriese AS, et al. Nephrol Dial Transplant. 2001 Nov;16(11):2143-5. doi: 10.1093/ndt/16.11.2143. Nephrol Dial Transplant. 2001. PMID: 11682658 Review. No abstract available.

10

Glucotoxicity of the peritoneal membrane: the case for VEGF.

De Vriese AS, Mortier S, Lameire NH. De Vriese AS, et al. Nephrol Dial Transplant. 2001 Dec;16(12):2299-302. doi: 10.1093/ndt/16.12.2299. Nephrol Dial Transplant. 2001. PMID: 11733619 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results